Funder: National Institutes of Health
Due Dates: July 23, 2025 (New/Renewal/Resubmission/Revision) | February 11, 2026 (New/Renewal/Resubmission/Revision) | July 23, 2026 (New/Renewal/Resubmission/Revision) | February 11, 2027 (New/Renewal/Resubmission/Revision)
Funding Amounts: No budget cap; budgets must reflect actual project needs. Maximum project period: 5 years. Cooperative agreement (U01).
Summary: Supports research to identify genetic, genomic, and molecular (epi)genetic variants underlying addiction-related phenotypes, substance use disorder (SUD) stages, associated behaviors, and comorbidities using animal models and multi-omics approaches.
Key Information: Clinical trials are not allowed. Foreign and domestic organizations are eligible. Data management and sharing plans are required.